ADMA Biologics Follows Up On RI-002
Seeking Alpha,
Summary acquired assets of Biotest Pharmaceuticals, including two FDA approved antibody products, manufacturing facility, and…
Summary acquired assets of Biotest Pharmaceuticals, including two FDA approved antibody products, manufacturing facility, and…
ADMA Biologics Inc (NASDAQ: ADMA ) is a micro (market cap: $72.74 million) biopharmaceutical company developing specialty plasma…